|
|
|
Dr Aaron Verty
B.A., M.A. (Poona), PhD (UNE)
Research Fellow - Department of Physiology
Return to Research Staff Index
| Address: |
Department of Physiology |
| |
Building 13F |
| |
Monash University VIC 3800 Australia |
| Located: |
Room FG27, Building 13F (Physiology) |
| at: |
Clayton Campus |
| Tel: |
+61 3 990 58660 |
| Fax: |
+61 3 990 52547 |
| Email: |
Aaron.Verty@med.monash.edu.au |
Research Interests
Aaron has a broad research interest in the areas of neuroscience and psychopharmacology. In particular, his PhD studies examined the modulatory and mediatory role of cannabinoid drugs (chemicals that bind to the same brain receptors as marijuana) in food intake. At present he is examining the the neural mechanisms that control thermogenesis, an important component of energy expenditure and therefore body weight.
Publications
Verty, A. N. A., McGregor, I. S., Mallet, P. E. (In press).
Paraventricular hypothalamic CB1 cannabinoid receptors are involved in
the feeding stimulatory effects of £G 9-tetrahydrocannabinol.
Neuropharmacology.
Verty, A. N. A., McGregor, I. S., Mallet, P. E. (2004) Consumption of
high carbohydrate, high fat, and normal chow is equally suppressed by a
cannabinoid antagonist in nondeprived rats. Neuroscience Letters, 354,
217-220
Verty, A. N. A., McFarlane, J. R., McGregor, I. S., Mallet, P. E.
(2004) Evidence for an interaction between CB1 cannabinoid and
melanocortin MCR-4 receptors in regulating food intake. Endocrinology,
145, 3224-3231
Verty, A. N. A., McFarlane, J. R., McGregor, I. S., Mallet, P. E.
(2004) Evidence for an interaction between CB1 cannabinoid and oxytocin
receptors in food and water intake. Neuropharmacology, 47, 593-603
Verty, A. N. A., McGregor, I. S., Mallet, P. E. (2004) The dopamine
receptor antagonist SCH 23390 attenuated feeding induced by
£G9-tetrahydrocannabinol. Brain Research, 1020, 188-195.
Singh, M. E., Verty, A. N. A., Price, I., McGregor, I. S., Mallet,
P.E.(2004) Modulation of morphine induced Fos-immunoreactivity by the
cannabinoid receptor antagonist SR 141716. Neuropharmacology, 47,
1157-1169.
Singh, M. E., Verty, A. N. A., McGregor, I. S., Mallet, P. E. (2004)
Cannabinoid Receptor Antagonist Attenuates Conditioned Place
Preference But Not Behavioral Sensitisation To Morphine. Brain
Research,1026, 244-253.
Verty, A. N. A., Singh, M. E., McGregor, I. S., Mallet, P. E. (2003)
The cannabinoid receptor antagonist SR 141716 attenuates overfeeding
induced by systemic or intracranial morphine. Psychopharmacology, 168,
314-323.
Return to top of page
|
